Bristol-Myers Squibb Co. (BMY) Social Stream
BRISTOL MYERS SQUIBB CO (BMY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BRISTOL MYERS SQUIBB CO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 14 | $80 | $66 | $73.222 | $71.23 | 2.8% |
| 2021-11-17 | 13 | $80 | $66 | $72.875 | $71.23 | 2.31% |
| 2021-11-18 | 12 | $80 | $66 | $72.875 | $71.23 | 2.31% |
| 2021-11-19 | 12 | $80 | $66 | $72.777 | $71.23 | 2.17% |
| 2022-02-07 | 13 | $80 | $58 | $71.3 | $71.23 | 0.1% |
| 2022-03-25 | 13 | $80 | $58 | $71.5 | $71.23 | 0.38% |
| 2022-03-30 | 13 | $81 | $58 | $72.4 | $71.23 | 1.64% |
| 2022-04-18 | 13 | $81 | $58 | $72.2 | $71.23 | 1.36% |
| 2022-04-22 | 13 | $85 | $58 | $73.7 | $71.23 | 3.47% |
| 2022-05-02 | 13 | $85 | $58 | $74.272 | $71.23 | 4.27% |
| 2022-05-16 | 13 | $92 | $58 | $75.818 | $71.23 | 6.44% |
| 2022-05-25 | 13 | $92 | $63 | $76.909 | $71.23 | 7.97% |
| 2022-06-01 | 14 | $92 | $63 | $78 | $71.23 | 9.5% |
| 2022-06-06 | 14 | $92 | $63 | $78.181 | $71.23 | 9.76% |
| 2022-07-27 | 15 | $92 | $63 | $78.181 | $71.23 | 9.76% |
| 2022-07-28 | 17 | $92 | $61 | $79.083 | $71.23 | 11.02% |
| 2022-08-30 | 17 | $92 | $61 | $78.769 | $71.23 | 10.58% |
| 2022-09-20 | 17 | $94 | $61 | $79.615 | $71.23 | 11.77% |
| 2022-10-12 | 18 | $94 | $61 | $79.615 | $71.23 | 11.77% |
| 2022-10-26 | 18 | $94 | $61 | $79.461 | $71.23 | 11.56% |
| 2022-10-31 | 18 | $94 | $60 | $79.23 | $71.23 | 11.23% |
| 2022-12-06 | 16 | $94 | $60 | $79.461 | $71.23 | 11.56% |
| 2023-01-09 | 17 | $94 | $60 | $80.076 | $71.23 | 12.42% |
| 2023-01-26 | 18 | $95 | $60 | $81.142 | $71.23 | 13.92% |
| 2023-01-30 | 18 | $95 | $60 | $81.285 | $71.23 | 14.12% |
The Trend in the Analyst Price Target
BMY's average price target has moved up $6.16 over the prior 23 months.
Over the past 52 weeks, BMY's average upside potential has been 5.48%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-22 | 13 | 85 | 58 | 73.700 | 75.75 | -2.71% |
| 2022-05-02 | 13 | 92 | 58 | 75.818 | 75.08 | 0.98% |
| 2022-05-16 | 13 | 92 | 58 | 75.818 | 76.91 | -1.42% |
| 2022-06-06 | 14 | 92 | 63 | 78.181 | 75.25 | 3.9% |
| 2022-09-14 | 17 | 94 | 61 | 79.615 | 70.47 | 12.98% |
BMY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.18 | 8 | 0 | 9 | 1 | 1 | 18 |
The Trend in the Broker Recommendations
BMY's average broker recommendation rating worsened by 0.27 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BRISTOL MYERS SQUIBB CO's number of analysts covering the stock is greater than 2404.53% of all US stocks.
- In terms of how BRISTOL MYERS SQUIBB CO fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 355.93% of that group.
- BRISTOL MYERS SQUIBB CO's average analyst price target is higher than 2349.96% of Pharmaceutical Products stocks.
- In terms of how BRISTOL MYERS SQUIBB CO fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -567.51% of that group.
Stocks similar to BRISTOL MYERS SQUIBB CO in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RPRX, CVAC, and MRVI.
View All Top Stocks by Price Target
Is BMY a Buy, Hold or Sell? See the POWR Ratings now!